Shadi Tabibian: November 2026 Hemophilia and Bleeding Disorders Bulletin
Shadi Tabibian, Deputy of research at Blood Diseases Research Centers in Iran University of Medical Sciences, shared a post on LinkedIn:
“I’m pleased to share the November 2026 issue (Issue 2) of ‘Tazehnameh’, the monthly bulletin of the Iranian Comprehensive Hemophilia Care Center (ICHCC), co owned by ICHCC and the Blood Diseases Research Center.
Published in Persian in the first week of each month, ‘Tazehnameh’ now also has an English mobile edition.
The PDF is attached. This issue covers news published from 23 September to 22 October 2026, drawn from peer reviewed articles and official announcements, rewritten in plain language and supported by numbered references.
Highlights include:
- FDA review of denecimig (Mim8), extended because of manufacturing site remediation, not clinical data
- Swiss consensus on desmopressin, recommending a trial before therapeutic use
- Launch of the WFH Treatment Guidelines Resource Hub
- New US ICD 10 CM code D69.11 for Glanzmann thrombasthenia, relevant to Iran, where Glanzmann is more common due to consanguinity
- Two high titer inhibitor cases after AAV gene therapy (ASC618), reported in Blood
- World Thrombosis Day 2026’s focus on women’s health, and two ‘How I’ papers in Blood on women and girls with bleeding disorders
The dossier, ‘Novel hemophilia therapies surgical and safety considerations,’ covers emicizumab in special situations, including Canadian registry data (n equal 710; mean ABR 1.00 to 0.47); rebalancing agents (fitusiran, concizumab, marstacimab) in surgery; 15 year EUHASS thrombosis baseline rates; and a patient checklist for before surgery or dental work.
Evidence on surgery, trauma and acute illness with these therapies remains limited.
Decisions should be made with the treatment center.”
Stay updated with Hemostasis Today.
-
Nov 5, 2026, 19:17Cedric Hermans: New HAVEN 6 Publication Highlights Emicizumab Outcomes in Mild and Moderate Haemophilia A
-
Nov 5, 2026, 19:08Ruchi Punamia: The Journey from Research to First Published Book Chapter on Single Donor Platelets
-
Nov 5, 2026, 18:57Maria Luszczyn: Does Blood Transfusion Really Worsen Long-Term Survival after CABG or is Preoperative Anemia the Main Driver?
-
Nov 5, 2026, 18:20Jessica Vega: How Listening to Patient Experience Reframes Warm Autoimmune Hemolytic Anemia Care
-
Nov 5, 2026, 18:15Paresh P Kulkarni: Frontiers in Immunology Launches Call for Papers on Innate Immune Mechanisms and Biomarkers in APS
-
Nov 5, 2026, 18:08Perrine Henry: Iliac Venous Thrombus Identified as Rare Cause of Hindlimb Lameness in Dog with Primary Erythrocytosis
-
Nov 5, 2026, 18:02Kellie Machlus: Bone Marrow Megakaryocytes Present Antigens and Regulate T Cells
-
Nov 5, 2026, 14:42Matteo Foschi: ASPERA-R Reveals the Challenges of Anticoagulation Resumption After Hemorrhagic Transformation
-
Nov 5, 2026, 14:30Khaled Musallam: Assessing the State of Thalassaemia and Sickle Cell Disease Care Across Europe